Why Us?
inPhronesis is part of inThought, a strategic advisory firm partnering with pharmaceutical and life science leaders throughout the product life cycle. Our consultants have a deep understanding of both the clinical and commercial aspects of the industry. The name “inPhronesis” comes from “Phronesis,” the ancient Greek word for a type of wisdom or intelligence. More specifically, a type of wisdom relevant to practical action.
We simplify the lives of life sciences leaders by organizing, evaluating, visualizing, & sharing insights from pipeline, market landscape and clinical data.
The inPhronesis team consists of industry analysts, technology experts, and seasoned customer success professionals and seamlessly partners with clients to ensure maximum insights and value is derived. We are a dedicated team who prioritize partnership and collaboration.
An AI-driven platform built specifically for life sciences designed to enhance efficiency by organizing, evaluating, visualizing, & sharing insights from pipeline, market landscape and clinical data.
© 2024 inPhronesis. All Rights Reserved.
As the president of inPhronesis, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.
With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.
Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.
